Affiliation:
1. Tigray Health Research Institute
2. Mekelle University
Abstract
Abstract
Background: With the advent of antiretroviral treatment, HIV related morbidity and mortality have tremendously decreased. However, some HIV patients on ART don’t optimally respond to the ART regimen to restore the immunity. This study was aimed to determine the pattern of CD4+ T cell recovery and determinants of HIV infected individuals receiving the ART in Mekelle Hospital, Tigray northern Ethiopia.
Methods: A hospital based retrospective cross-sectional study was conducted from January, 2010 to August, July 2020 among HIV positive individuals on ART follow up. Data were collected using pre-tested structured questionnaire by trained data collector. Statistical analysis was performed using SPSS V. 20. Bivariate and multivariate analyses were performed to identify the possible predictors for immune reconstitution after ART administration. P-values < 0.05 was considered statistically significant.
Results: Of the total 424 study participants, 248(58%) were females. The mean age of the study participants was 37+9 (mean + sd). The median time of ART follow up was 60 (IQR: 36-84) months and the recent median CD4+ T-cell count was 388 (IQR; 254-527) cells/µl. The CD4 cell count increment compared to pre-ART was 166 cells/µl of blood. Age ranges 25-34 years (AOR 2.62, 95%CI: 0.82-8.35), CD4+ T-cell count >200 cells/µl at baseline (AOR 3.53, 95%CI: 2.23-5.58), duration of ART follow up at 12, 48 and 49 and above months respectively (AOR 8.053, 95%CI:1.45-44.84; 4.82, 95%CI:1.16-20.11); and (AOR 6.36, 95%CI:1.63-24.77), and TDF-3CT-Efv ART regimen combination (AOR 2.29, 95%CI:1.32-3.97) were found predictors significantly associated with CD4+ T-cell recovery after long term ART uptake, which characterized by >350 cells/µl increments.
Conclusions: The immune restoration of HIV positive individuals depends on the length of ART follow up time and CD4+ T-cell level during the initiation. Moreover, individuals who were taking TDF-3CT-Efv ART drug combination demonstrated a rapid CD4+ T-cell restoration than these who were taking other ART drug regimens.
Publisher
Research Square Platform LLC
Reference50 articles.
1. Joint United Nations Programme on HIV/AIDS. Seizing the moment - Tackling entrenched in equalities to end epidemics. Geneva: UNAIDS. ; 2020. Available from: https://www.un.org/sexualviolenceinconflict/wp-content/uploads/2020/07/report/global-aids- 370 update-seizing-the-moment-tackling-entrenched-inequalities-to-endepidemics/2020_global-aids-report_en.pdf.
2. Global HIV. & AIDS Statistics — 2020 Fact Sheet. Joint United Nations Programme on HIV/AIDS 2020. https://www.unaids.org/en/resources/fact-sheet.
3. World Health Organization. HIV/AIDS. 2020 Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids
4. Federal Democratic Republic of Ethiopia, Ministry of Health. Health sector Transformation plan –I.annual performance report 2016/17. Addis Ababa, Ethiopia: FMOH; 2017. pp(48–51).
5. Maya MT, Gompelsb M, Delpechc V, Porterd K, Orkine C, Keggf S et al. Impact on life expectancy of HIV-1 positive individuals of CD4R cell count and viral load response to antiretroviral therapy. AIDS. 2014. 28:1193–1202. Available from: DOI:10.1097/QAD.0000000000000243
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献